Literature DB >> 7746176

Changes in the use of hormone replacement therapy in South Australia.

A H MacLennan1, A W Taylor, D H Wilson.   

Abstract

OBJECTIVE: To determine changes in the use of hormone replacement therapy (HRT) in South Australia between 1991 and 1993. DESIGN AND
SETTING: Survey of women aged 40 years and over, as part of the 1991 and 1993 South Australian Health Omnibus Surveys (household interviews); 868 were interviewed in 1991 and 790 in 1993. OUTCOME MEASURES: Rates of HRT use.
RESULTS: In 1993, 19.0% of women aged 40 years and over were taking HRT and 28.5% had ever taken it (currently or in the past). The highest rates were in the 50-54 years age group (46.2% current use and 57.8% ever use). Between 1991 and 1993 there was a 40% increase in the number of women taking HRT and a significant increase (P < 0.01) in the median duration of therapy, from 38 to 54 months. There were also significant increases in rates of use by country women and Australian-born women (P < 0.01). Premarin and Provera remained the most commonly used products in 1993.
CONCLUSION: Australian perimenopausal women are increasingly using HRT. This may reflect recent educational programs on the menopause for both health professionals and the public, and also an increasing number of choices of therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746176

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

Review 1.  Hormone replacement therapy and breast cancer: estimate of risk.

Authors:  Nathan J Coombs; Richard Taylor; Nicholas Wilcken; John Boyages
Journal:  BMJ       Date:  2005-08-06

2.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

3.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.